BOM Brabant Ventures

BOM Brabant Ventures is an incubator and growth accelerator with over 35 years of experience, dedicated to supporting ambitious companies in the Brabant region. The organization provides knowledge and risk capital to facilitate the growth of startups and scaleups, focusing on key industries such as High Tech Systems and Materials, Agrofood, Biobased Economy, Life Sciences and Medtech, Maintenance, and Supply Chain. Through its expertise, BOM Brabant Ventures aims to foster sustainable development and innovation within these sectors, ensuring the long-term success of its portfolio companies.

Remie Bastiaansen

Investor

Ernst Coolen

Investor

Sjoerd Coolen

Investor

Keshia Engels

Analyst

Jos Feijen

Investor

Floris Hamel

Investor

Robin Hendrickx

Investor

Lieven Huang

Investor

Stephan Hulsbergen

Analyst

Ilse Massart

Investor

Bart Mul

Investor

Ingrid Nieweg

Investor

Mercedes Tuin

Investor

Paul Vernooij

Analyst

Jeroen Willems

Investor

Koen den Houting

Investor

Brigit van Dijk - van de Reijt

Investor

Jurgen van Eck

Investor

Daan van Lange

Associate

Bart van den Heuvel

Associate

23 past transactions

SamanTree Medical

Series B in 2024
Founded in 2014 and based in Ecublens, Switzerland, SamanTree Medical develops digital microscopy systems using micro-optics for research, diagnostics, and surgeries. Its flagship product is a surgical digital microscope that enables real-time visualization of living tissue structure, enhancing surgical decision-making and reducing re-operation rates.

Microsure

Series B in 2023
Founded in 2014, Microsure specializes in enhancing microsurgical procedures. Its flagship product is a motion stabilizer system designed by and for microsurgeons to overcome physical limitations and improve surgical precision. This technology has successfully been used in clinical trials, with the aim of increasing treatment options for patients.

Sirius Medical

Series B in 2023
Sirius Medical helps improve healthcare for cancer patients by developing medical devices that aid in surgical treatment. Their objective is to create intuitive and accurate gadgets that allow surgeons and radiologists to provide the finest treatment. Sirius Perception uses audio and visual feedback to provide real-time, directional advice for pinpointing tumors

Scailable

Seed Round in 2022
Scailable is a management platform designed for developers to create and manage plug-and-play edge artificial intelligence (AI) solutions efficiently. The company provides a robust platform that enables the deployment, monitoring, and governance of AI and machine learning models across various environments, including cloud, browser, and edge devices. Scailable's technology integrates seamlessly into continuous delivery pipelines, allowing developers to establish their own AI model management interfaces. This approach facilitates secure and modular access to AI services, ensuring functionality even on devices with minimal memory. By streamlining the deployment process, Scailable empowers clients to leverage AI capabilities effectively while maintaining control over their applications.

STENTiT

Seed Round in 2022
STENTiT is a medical device company that originated as a spin-off from the Eindhoven University of Technology in the Netherlands. The company specializes in the development of regenerative endovascular implants, specifically biodegradable stents designed to restore arteries. STENTiT's innovative products aim to trigger a natural healing response in patients, allowing blood cells to replace the implant with new vascular tissue. This approach enables medical professionals to effectively treat patients suffering from cardiovascular diseases by promoting internal restoration of the affected arteries.

Sirius Medical

Series A in 2021
Sirius Medical helps improve healthcare for cancer patients by developing medical devices that aid in surgical treatment. Their objective is to create intuitive and accurate gadgets that allow surgeons and radiologists to provide the finest treatment. Sirius Perception uses audio and visual feedback to provide real-time, directional advice for pinpointing tumors

Ctrlchain

Seed Round in 2021
CtrlChain focuses on simplifying and automating logistics management to enhance profitability, visibility, and service levels for shippers and carriers. The company provides streamlined, centralized systems for managing freight, which reduce manual operations and costs while offering data-driven insights to optimize transport operations. CtrlChain's online logistics software is designed to handle both regular and urgent shipments sustainably, featuring live tracking, order history, easy booking, and instant availability for courier requests. By making optimal use of existing transport capacity, the company ensures timely and safe delivery of packages and couriers for businesses and other clients.

Scailable

Pre Seed Round in 2021
Scailable is a management platform designed for developers to create and manage plug-and-play edge artificial intelligence (AI) solutions efficiently. The company provides a robust platform that enables the deployment, monitoring, and governance of AI and machine learning models across various environments, including cloud, browser, and edge devices. Scailable's technology integrates seamlessly into continuous delivery pipelines, allowing developers to establish their own AI model management interfaces. This approach facilitates secure and modular access to AI services, ensuring functionality even on devices with minimal memory. By streamlining the deployment process, Scailable empowers clients to leverage AI capabilities effectively while maintaining control over their applications.

Orbisk

Seed Round in 2021
Orbisk is a developer of fully automated food waste monitoring equipment aimed at enhancing sustainability within the food service industry. The company's innovative solution includes a smart camera equipped with an artificial intelligence image recognition algorithm that identifies food ingredients from images. By integrating this technology into waste bins, Orbisk enables hospitality organizations to gain comprehensive insights into their food waste, quantifying large volumes of discarded food. This data-driven approach allows restaurants to identify inefficiencies in their food-providing processes, facilitating significant reductions in food waste and contributing to improved sustainability and profitability.

Trabotyx

Seed Round in 2021
Trabotyx specializes in agricultural robotics, developing a platform of autonomous single-row weeding robots. Their adaptable wheelbase accommodates diverse field layouts, targeting weeds within 5 centimeters to 1 centimeter of plants, reducing manual labor demands for organic farmers while enhancing biodiversity and soil health.

Microsure

Series B in 2021
Founded in 2014, Microsure specializes in enhancing microsurgical procedures. Its flagship product is a motion stabilizer system designed by and for microsurgeons to overcome physical limitations and improve surgical precision. This technology has successfully been used in clinical trials, with the aim of increasing treatment options for patients.

Shypple

Series A in 2021
Shypple is a digital freight forwarder that specializes in optimizing global supply chains through advanced technology. The company is comprised of a team with extensive backgrounds in logistics, international trade, and forwarding, which drives their mission to streamline the process of booking, managing, and tracking freight shipments. Shypple's platform features a digital dashboard that serves as a central hub for information, enhancing collaboration among all stakeholders in the logistics process. By offering routing options, price comparisons from various carriers, and real-time shipment visibility, Shypple aims to improve accountability and efficiency in international trade while maintaining the personal service expected from traditional forwarders. This approach allows enterprises to navigate the complexities of global freight movement with greater ease and transparency.

Orbisk

Pre Seed Round in 2020
Orbisk is a developer of fully automated food waste monitoring equipment aimed at enhancing sustainability within the food service industry. The company's innovative solution includes a smart camera equipped with an artificial intelligence image recognition algorithm that identifies food ingredients from images. By integrating this technology into waste bins, Orbisk enables hospitality organizations to gain comprehensive insights into their food waste, quantifying large volumes of discarded food. This data-driven approach allows restaurants to identify inefficiencies in their food-providing processes, facilitating significant reductions in food waste and contributing to improved sustainability and profitability.

Xyall

Series A in 2020
Xyall is a global innovator in the field of molecular pathology, specializing in advanced tissue dissection technology. The company has developed a platform that automates and digitizes the tissue dissection workflow, enhancing accuracy and efficiency in molecular diagnostics. This technology not only scales with demand but also reduces operational costs and minimizes the risk of cross-contamination. Additionally, it ensures traceability for each sample and test, allowing pathologists to obtain reliable diagnostic results in real-time. Through its innovative solutions, Xyall aims to improve the quality and reliability of molecular pathology services.

Knowingo+

Seed Round in 2019
Knowingo provides live data and statistics on employees’ knowledge levels across different topics.

Citryll

Series A in 2019
Citryll is a private pharmaceutical company based in Oss, The Netherlands, established in 2015. The company specializes in the development of pharmaceutical drugs aimed at treating autoimmune and other human diseases. Citryll's innovative approach focuses on the formation, function, and clearance of neutrophil extracellular traps (NETs) that are associated with the protein citrullination pathway, which is catalyzed by Peptidylarginine Deiminase (PAD) enzymes. This research and development are instrumental in providing treatment options for various conditions, including lupus, vasculitis, pulmonary fibrosis, rheumatoid arthritis, and organ damage resulting from sepsis.

DENS

Seed Round in 2019
Dutch Energy Systems specializes in Hydrozine solutions that generate hydrogen and electricity independently from the power grid. These solutions help reduce emissions by replacing diesel fuel in heavy-duty vehicles and machinery across industries like agriculture, construction, and others.

SamanTree Medical

Series A in 2019
Founded in 2014 and based in Ecublens, Switzerland, SamanTree Medical develops digital microscopy systems using micro-optics for research, diagnostics, and surgeries. Its flagship product is a surgical digital microscope that enables real-time visualization of living tissue structure, enhancing surgical decision-making and reducing re-operation rates.

CytoSMART Technologies

Series B in 2019
CytoSMART Technologies, founded in 2012 and based in the Netherlands, specializes in the development and manufacturing of innovative devices for cell culture monitoring and counting. The company's product lineup includes the CytoSMART Lux2, CytoSMART Exact, and CytoSMART Omni, which integrate advanced technology with custom software to improve the efficiency of cell culture processes. These devices enable researchers to monitor cell growth remotely, reducing the need for constant laboratory presence. CytoSMART's clientele includes prestigious institutions and organizations such as Fontys, THM, Roche, the University of Oxford, EMBL, and the University of St Andrews, highlighting its commitment to enhancing research capabilities in laboratories worldwide.

ENPICOM

Series A in 2019
ENPICOM is a bioinformatics software company that develops technology-agnostic, code-free software to manage and analyze immune repertoire sequencing data and to support antibody discovery. It provides products and customized solutions to researchers in biopharma and academic centers, helping accelerate the discovery and development of novel immunotherapies and vaccines and enabling scientists to focus on research and breakthroughs.

Additive Industries

Debt Financing in 2019
Founded in 2012, Additive Industries designs and manufactures industrial metal additive manufacturing systems. Headquartered in Eindhoven, Netherlands, the company offers modular 3D printing systems and integrated information platforms tailored for high-end industrial markets such as aerospace, automotive, medical technology, and high-tech equipment.

DegenRx B.V.

Series A in 2018
DegenRx is a biotech startup working on AAV-mediated gene therapy for CNS disorders like Parkinson's and Alzheimer's. They transmit genes to the brain that start the local synthesis of therapeutic antibodies using adeno-associated-viral vectors. Its goal is to discover and create treatments for neurodegenerative disorders so people can age longer and healthier.

CytoSMART Technologies

Series A in 2016
CytoSMART Technologies, founded in 2012 and based in the Netherlands, specializes in the development and manufacturing of innovative devices for cell culture monitoring and counting. The company's product lineup includes the CytoSMART Lux2, CytoSMART Exact, and CytoSMART Omni, which integrate advanced technology with custom software to improve the efficiency of cell culture processes. These devices enable researchers to monitor cell growth remotely, reducing the need for constant laboratory presence. CytoSMART's clientele includes prestigious institutions and organizations such as Fontys, THM, Roche, the University of Oxford, EMBL, and the University of St Andrews, highlighting its commitment to enhancing research capabilities in laboratories worldwide.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.